The Ensign Group (NASDAQ:ENSG) Shares Gap Up on Strong Earnings

Key Points

• Ensign’s shares jumped 7.3% after the company reported quarterly EPS of $2.03, beating the $1.97 consensus and rising from $1.64 a year earlier. Revenue increased 14.5% year over year to $1.48 billion but fell short of the roughly $1.51 billion estimate.
• The company raised its 2026 earnings guidance, reinforcing analyst optimism; Ensign carries a consensus “Moderate Buy” rating with an average price target of $216.25.
• Legal and reputational risks remain significant. Securities-fraud lawsuits and investor notices followed allegations from a short-seller report involving patient care, staffing, data and billing practices; the allegations have not been proven in court.

The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report)'s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $169.50, but opened at $178.23. The Ensign Group shares last traded at $182.9770, with a volume of 81,474 shares traded.

The company reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.97 by $0.06. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same period last year, the company earned $1.64 EPS. The firm's revenue for the quarter was up 14.5% compared to the same quarter last year.

The Ensign Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Saturday, October 31st. Shareholders of record on Wednesday, September 30th will be issued a $0.0650 dividend. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date is Wednesday, September 30th. The Ensign Group's dividend payout ratio is currently 4.08%.

Key Stories Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: 2026 earnings guidance was raised. Ensign increased its full-year earnings outlook, signaling confidence in operating trends and supporting expectations for continued earnings growth. UBS analyst A.J. Rice reiterated a Buy rating following the update. The Ensign Group Raises Earnings Guidance for 2026 UBS Reiterates Buy on Ensign
• Positive Sentiment: Third-quarter EPS beat expectations. Ensign reported earnings of $2.03 per share, above the $1.94–$1.97 consensus range and up from $1.64 a year earlier. Revenue rose 14.5% year over year to $1.48 billion, demonstrating continued growth in the business. Ensign Reports Third-Quarter 2026 Results
• Neutral Sentiment: Revenue fell short of estimates. Although sales increased substantially year over year, the $1.48 billion result was below the approximately $1.51 billion analyst forecast, creating a mixed quarterly performance. Ensign Reports Sales Below Estimates
• Negative Sentiment: Legal and reputational risks are pressuring the stock. Multiple law firms announced securities-fraud class actions or investor notices after a short-seller report alleged patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. These allegations have not been established in court, but the reports contributed to a sharp decline in ENSG shares and may increase litigation and regulatory uncertainty. The lead-plaintiff deadline is December 7, 2026. Ensign Securities-Fraud Lawsuit Alert

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Wall Street Zen upgraded The Ensign Group from a "hold" rating to a "buy" rating in a research note on Sunday. Weiss Ratings upgraded The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Truist Financial upped their price objective on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a research note on Thursday, July 30th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $228.00 target price on shares of The Ensign Group in a report on Tuesday, July 28th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, The Ensign Group has a consensus rating of "Moderate Buy" and an average target price of $216.25.

Institutional Investors Weigh In On The Ensign Group

A number of hedge funds have recently made changes to their positions in ENSG. BlackRock Inc. purchased a new position in The Ensign Group in the second quarter valued at about $937,218,000. Wasatch Advisors LP raised its holdings in The Ensign Group by 10.7% in the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company's stock worth $365,215,000 after purchasing an additional 220,329 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in The Ensign Group by 7.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company's stock worth $92,220,000 after purchasing an additional 30,521 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of The Ensign Group during the second quarter valued at about $65,470,000. Finally, Paradigm Capital Management Inc. NY purchased a new stake in shares of The Ensign Group during the second quarter valued at about $54,742,000. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

The Ensign Group Stock Up 7.3%

The firm has a market capitalization of $10.60 billion, a PE ratio of 28.52 and a beta of 0.66. The company's 50-day simple moving average is $174.65 and its 200 day simple moving average is $181.46.

The Ensign Group Company Profile

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.